Do What the Locals Do - BUY Celltrion/Samsung Bio/SK Holdings on SK Biopharma Listing
Local institutions in Korea will have a significant underperformance on SK Biopharm listing and will clamor to buy and makeup for their...
502 Views
SK Biopharmaceuticals: Immediate Post IPO Float Is 13% (Not 5%)
What's the post-IPO float of SK Biopharm?It is much higher than what it first appeared after the book-building.Below is the final allocation....
603 Views
KB Bank Sells 2.5% Stake in SK Holdings in a Block Deal
Yesterday, KB Kookmin Bank sold about 2.5% of its stake in SK Holdings (034730 KS) for about 500 billion won in a "club deal basis" to foreign...
479 Views
KOSPI200 Index Rebalance Preview - Positioning Begins for December
The Korea Exchange (KRX) will announce the results of the December 2020 review of the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) in...
1k Views
SK Biopharmaceuticals IPO Book-Building Results & Ramifications
Yes, it is a new record. The competition rate is 836 to 1, which is the highest among the ₩500bil+ IPOs in Korea. The previous record-holder was...
567 Views